-
Likelihood of Approval and Phase Transition Success Rate Model - LGK-974 in Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LGK-974 in Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LGK-974 in Lung Cancer Drug Details: LGK-974 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - Avicursen in Relapsing Remitting Multiple Sclerosis (RRMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avicursen in Relapsing Remitting Multiple Sclerosis (RRMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avicursen in Relapsing Remitting Multiple Sclerosis (RRMS) Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Anifrolumab in Dermatomyositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anifrolumab in Dermatomyositis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anifrolumab in Dermatomyositis Drug Details: Anifrolumab (Saphnelo) is a immunoglobulin G1 kappa...
-
Likelihood of Approval and Phase Transition Success Rate Model - BXQ-350 in Malignant Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BXQ-350 in Malignant Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BXQ-350 in Malignant Glioma Drug Details: BXQ-350 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - Nerofe in Alzheimer's Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nerofe in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nerofe in Alzheimer's Disease Drug Details: Nerofe is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - NBM-BMX in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NBM-BMX in Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NBM-BMX in Glioblastoma Multiforme (GBM) Drug Details: NBM-01 (NBMTBMXOS-01) is...
-
Likelihood of Approval and Phase Transition Success Rate Model - Tolinapant in T-Cell Lymphomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tolinapant in T-Cell Lymphomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tolinapant in T-Cell Lymphomas Drug Details: Tolinapant (ASTX-660) (AT-IAP) is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - Dupilumab in Unspecified Respiratory Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dupilumab in Unspecified Respiratory Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dupilumab in Unspecified Respiratory Disorders Drug Details: Dupilumab (REGN-668, SAR231893,...
-
Likelihood of Approval and Phase Transition Success Rate Model - Ibrance in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ibrance in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ibrance in Metastatic Breast Cancer Drug Details: Palbociclib (Ibrance, Agatha)...
-
Likelihood of Approval and Phase Transition Success Rate Model - Carfilzomib in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Carfilzomib in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Carfilzomib in Acute Lymphocytic Leukemia (ALL,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.